-
Product Name
TBCE antibody
- Documents
-
Description
TBCE Rabbit Polyclonal antibody. Positive IHC detected in human prostate cancer. Positive WB detected in human liver tissue, COLO 320 cells, HeLa cells, human brain tissue, SH-SY5Y cells. Observed molecular weight by Western-blot: 59kd
-
Tested applications
ELISA, WB, IHC
-
Species reactivity
human, mouse, rat; other species not tested.
-
Alternative names
TBCE antibody; tubulin folding cofactor E antibody; HRD antibody; KCS antibody; Tubulin specific chaperone E antibody
-
Isotype
Rabbit IgG
-
Preparation
This antibody was obtained by immunization of TBCE recombinant protein (Accession Number: NM_003193). Purification method: Antigen affinity purified.
-
Clonality
Polyclonal
-
Formulation
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:500-1:5000
IHC: 1:20-1:200
-
Validations
human liver tissue were subjected to SDS PAGE followed by western blot with Catalog No:115873(TBCE antibody) at dilution of 1:500
Immunohistochemical of paraffin-embedded human prostate cancer using Catalog No:115873(TBCE antibody) at dilution of 1:50 (under 10x lens)
-
Background
TBCE represents tubulin folding cofactor E
-
References
- Biernacki MA, Marina O, Zhang W. Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cells. Cancer research. 70(3):906-15. 2010.
- Rak K, Frenz S, Radeloff A. Mutation of the TBCE gene causes disturbance of microtubules in the auditory nerve and cochlear outer hair cell degeneration accompanied by progressive hearing loss in the pmn/pmn mouse. Experimental neurology. 250:333-40. 2013.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"